Ellen de Brabander - Mar 1, 2022 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President of Innovation and Regulatory Affairs
Signature
/s/ Collin Smyser, Attorney-in-Fact for Ellen de Brabander
Stock symbol
ELAN
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 07:58 PM
Previous filing
Nov 8, 2021
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +14.5K +31.77% $0.00 60.1K Mar 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +38.5K $0.00 38.5K Mar 1, 2022 Common Stock 38.5K $28.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.
F2 Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025.

Remarks:

Executive Vice President of Innovation and Regulatory Affairs